| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |